Patent Application Titled "Bioactive Peptides And Methods Of Use Thereof" Published Online (USPTO 20250018012).

The patent application titled "Bioactive Peptides And Methods Of Use Thereof" discusses the treatment of cytokine release syndrome (CRS) and acute respiratory distress syndrome (ARDS) caused by infections like COVID-19. The application proposes a novel method using peptides to modulate the interaction between CD40 complex and CD154 proteins to reduce inflammation and cytokine levels. This treatment approach aims to address the severe immune response associated with CRS and ARDS, offering potential therapeutic benefits for patients with these conditions. [Extracted from the article]